ESR1 and breast carcinoma: Using two breast cancer cell lines, estrogen receptor (ER)-HS-578T and ER+MCF-7 cells, Yang et al., suggested the potential involvement of MAPK and STAT pathways in NCTD-induced programmed cell death [34].